Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Sanofi researchers modify heparin structure to improve on therapeutic properties

Aug. 20, 1999

RWJ-56110: first report of a new antithrombotic targeting the PAR-1 receptor

Aug. 20, 1999

Positive results shown in phase III interim analysis of Neutralase

Aug. 20, 1999

SanOrg-34006, a promising new antithrombotic, is safe for use in the elderly

Aug. 19, 1999

P2T antagonist shows antithrombotic effects in blood from patients with unstable angina

Aug. 19, 1999

Fibrinogen antagonist gantofiban is a promising treatment for peripheral arterial occlusion

Aug. 19, 1999

Sucrose-formulated rFVIII: a safe and effective second-generation factor VIII developed by Bayer

Aug. 19, 1999

Novel platelet ADP inhibitors reported by Cor Therapeutics

Aug. 18, 1999

CPMP declines to recommend approval of saruplase marketing application

Aug. 18, 1999

Sanofi-Synthelabo, Akzo Nobel collaborate in the study of factor Xa inhibitors

Aug. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...